Bitcoin is hovering around all-time highs. » Read More
By: Jeff Daniels
Shares of craft brewer Boston Beer slipped 5 percent after a disappointing outlook and continued weakness in key brands, including Sam Adams. » Read More
By: Robert Hum
There have been 27 years when the S&P 500 has risen in each of the first two months of the year. Here's what happens next. » Read More
JPMorgan initiates coverage on IAC with an overweight rating.
An emerging market benchmark fell sharply on Tuesday, as a strong dollar and Samsung's sell-off weighed on the ETF.
Todd Gordon of TradingAnalysis.com makes a bet to short health care.
Crude supplies fell for the first time since March, IEA reports, but an increase in petroleum products looms.
Economists now see a 75 percent chance of a Fed rate hike by the end of the year, largely because the GOP candidate is doing worse in the polls.
Samsung could bounce back from its recent exploding-phone scandal if the company focuses on its more profitable areas.
Top-ranked analyst Sam Poser of SIG initiated Nike with a positive rating on Tuesday, citing a "rare opportunity" to buy the stock on the recent pullback.
Twitter shares reverse course after two firms made bullish calls on the stock, based on fundamentals and a potential upside for the stock.
Financials are in focus this week as three major banks gear up to report earnings — but traders aren't expecting nearly as many fireworks as in the last few quarters.
Alcoa says revenue was down 6 percent year on year, due to the impact of "curtailed and closed operations, lower alumina pricing" and other pressures.
Jim Cramer educates investors on the signals to watch for that indicate that a stock is overheated, and it's time to sell.
Jim Cramer teaches investors to look for the signs that a stock has become overbought, and how to avoid getting burned.
Jim Cramer shares his top technique to combat volatility and profit in the stock market over time.
Jim Cramer shares his techniques to determine when a stock is flashing signals for a raging buy.
Jim Cramer reveals his methodology behind picking stocks, and determining the best entry point.
Now that earnings season is here, are third-quarter revenue estimates too high?
Shares of Tesaro jumped more than 20 percent on Monday after positive results for their drug niraparib, a potential treatment for ovarian cancer.
The popular EEM emerging markets ETF has done thrice as well as the S&P 500 this year. Here's why the run could continue.
While the election won't likely have a big effect on the overall market, certain sectors will be impacted, BlackRock's Russ Koesterich says.
Morgan Stanley tells investors to buy industrial stocks. Here's why...
Get the best of CNBC in your inbox